Paul A Carpenter
Overview
Explore the profile of Paul A Carpenter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
3981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munshi P, Olin R, Wall S, McCurdy S, Al-Juhaishi T, Baker J, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39961473
Geriatric assessment (GA) may identify vulnerabilities and promote risk-stratification in older adults predisposed to toxicities after autologous (auto), allogeneic (allo) hematopoietic cell transplantation (HCT) and chimeric antigen T-cell therapies (CAR...
2.
Douglas A, Douglas A, Lamoth F, Lamoth F, John T, John T, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39923936
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to create a guideline focusing on non-Aspergillus invasive...
3.
Davila S, Davila Saldana B, Davila Saldana B, Schultz K, Schultz K, Ramgopal A, et al.
Transplant Cell Ther
. 2025 Jan;
PMID: 39855565
While highly morbid forms of chronic graft versus host disease (cGVHD) and severe late effects of allogeneic hematopoietic cell transplantation (HCT) can impact children and adults alike, unique considerations arise...
4.
Bhatt N, Harris A, Gorfinkel L, Ibanez K, Tkaczyk E, Mitchell S, et al.
Transplant Cell Ther
. 2024 Dec;
31(2):69.e1-69.e18.
PMID: 39701289
Current literature lacks details on the impact of pediatric chronic graft-versus-host disease (cGVHD) on long-term survivorship after allogeneic hematopoietic cell transplantation (HCT). Nonetheless, cGVHD remains a leading cause of post-transplant...
5.
Sanchez E, Krantz E, Kassamali Escobar Z, Tverdek F, Rosen E, Ueda Oshima M, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae570.
PMID: 39450393
Background: There are limited data on the contemporary epidemiology of recurrent infection (CDI) among hematopoietic cell transplant (HCT) recipients. We aimed to determine the incidence, risk factors, and outcomes for...
6.
Ueda Oshima M, Higgins J, Jenkins I, Randolph T, Smith T, Valentine 3rd C, et al.
Sci Transl Med
. 2024 Oct;
16(770):eado5108.
PMID: 39441907
After allogeneic hematopoietic cell transplantation (HCT), a very small number of donor stem cells reconstitute the recipient hematopoietic system, whereas the donor is left with a near-normal pool of stem...
7.
Wickline M, Carpenter P, Harris J, Iribarren S, Reding K, Pike K, et al.
Vaccine
. 2024 Oct;
42(26):126374.
PMID: 39437647
Revaccination to restore immunity to vaccine-preventable diseases (VPDs) is essential risk mitigation in the prevention of infectious morbidity and mortality after hematopoietic cell transplantation (HCT). However, revaccination rates have been...
8.
Ogimi C, Xie H, Waghmare A, Jerome K, Leisenring W, Ueda Oshima M, et al.
Bone Marrow Transplant
. 2024 Oct;
59(12):1790.
PMID: 39394376
No abstract available.
9.
Wickline M, Carpenter P, Harris J, Iribarren S, Reding K, Pike K, et al.
Transpl Infect Dis
. 2024 Oct;
26(6):e14388.
PMID: 39373644
Background: Hematopoietic cell transplant (HCT) survivorship care includes recommendations for post-HCT revaccination to restore immunity to vaccine-preventable diseases (VPDs). However, not all survivors agree to be vaccinated. No existing studies...
10.
Iftikhar R, DeFilipp Z, DeZern A, Pulsipher M, Bejanyan N, Burroughs L, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1155-1170.
PMID: 39307421
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for severe aplastic anemia (SAA). Existing guidance about HCT in SAA is primarily derived from expert reviews, registry data and...